Israel Englander’s Core Laboratories CLB Stock Holding History

Israel Englander’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-1,900	Closed	-$321K	–	3473
2013 Q3	$321K	Buy	+1,900	New	+$295K	﹤0.01%	2823

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Israel Englander's CLB Position: Q2 2026 in Review

Israel Englander sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 23,802 shares — an estimated $400K sold.

Israel Englander first reported a position in CLB in Q4 2013 and held it in 32 quarters. The position peaked at $75.6M in Q2 2017. 185 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

Israel Englander reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
Israel Englander sold 23,802 Core Laboratories shares in Q2 2026, an estimated $400K.
Israel Englander first reported a position in Core Laboratories in Q4 2013 and held it in 32 quarters.
Israel Englander's Core Laboratories position peaked at $75.6M in Q2 2017.
185 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.